937 related articles for article (PubMed ID: 7616634)
61. Prophylactic lower para-aortic irradiation using intensity-modulated radiotherapy mitigates the risk of para-aortic recurrence in locally advanced cervical cancer: A 10-year institutional experience.
Lee J; Lin JB; Chang CL; Jan YT; Sun FJ; Wu MH; Chen YJ
Gynecol Oncol; 2017 Jul; 146(1):20-26. PubMed ID: 28457584
[TBL] [Abstract][Full Text] [Related]
62. Continuous 7-days-a-week external beam irradiation in locally advanced cervical cancer: final results of the Phase I/II study.
Serkies K; Dziadziuszko R; Jassem J
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1256-61. PubMed ID: 21570204
[TBL] [Abstract][Full Text] [Related]
63. A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer.
Thomas G; Dembo A; Ackerman I; Franssen E; Balogh J; Fyles A; Levin W
Gynecol Oncol; 1998 May; 69(2):137-45. PubMed ID: 9600821
[TBL] [Abstract][Full Text] [Related]
64. Pulsed low dose rate brachytherapy for uterine cervix carcinoma.
Rogers CL; Freel JH; Speiser BL
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):95-100. PubMed ID: 9989519
[TBL] [Abstract][Full Text] [Related]
65. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
66. Impact of primary para-aortic lymphadenectomy on distant failure in locally advanced cervical cancer patients treated in the era of image-guided adaptive brachytherapy.
Chargari C; Mazeron R; Dunant A; Gouy S; Petit C; Maroun P; Uzan C; Annede P; Bentivegna E; Balleyguier C; Genestie C; Pautier P; Leary A; Lhomme C; Deutsch E; Morice P; Haie-Meder C
Clin Exp Metastasis; 2016 Dec; 33(8):775-785. PubMed ID: 27530648
[TBL] [Abstract][Full Text] [Related]
67. Does para-aortic irradiation reduce the risk of distant metastasis in advanced cervical cancer? A systematic review and meta-analysis of randomized clinical trials.
Sapienza LG; Gomes MJL; Calsavara VF; Leitao MM; Baiocchi G
Gynecol Oncol; 2017 Feb; 144(2):312-317. PubMed ID: 27908530
[TBL] [Abstract][Full Text] [Related]
68. Escalated radiation and prophylactic extended field nodal irradiation are beneficial for FIGO IIIB cervical cancer patients' prognosis.
Meng Q; Wang W; Liu X; Hou X; Lian X; Sun S; Yan J; Liu Z; Miao Z; Hu K; Zhang F
Radiat Oncol; 2018 Nov; 13(1):223. PubMed ID: 30453993
[TBL] [Abstract][Full Text] [Related]
69. Twice-daily fractionation of external irradiation with brachytherapy in bulky carcinoma of the cervix. Phase I/II study of the Radiation Therapy Oncology Group 88-05.
Komaki R; Pajak TF; Marcial VA; Rotman M; Grigsby PW; Leibel SA; Eifel PJ
Cancer; 1994 May; 73(10):2619-25. PubMed ID: 8174061
[TBL] [Abstract][Full Text] [Related]
70. Radiation therapy alone in the treatment of carcinoma of uterine cervix. I. Analysis of tumor recurrence.
Perez CA; Breaux S; Madoc-Jones H; Bedwinek JM; Camel HM; Purdy JA; Walz BJ
Cancer; 1983 Apr; 51(8):1393-402. PubMed ID: 6402291
[TBL] [Abstract][Full Text] [Related]
71. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.
Petereit DG; Sarkaria JN; Potter DM; Schink JC
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1267-74. PubMed ID: 10613322
[TBL] [Abstract][Full Text] [Related]
72. FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma.
Singh AK; Grigsby PW; Dehdashti F; Herzog TJ; Siegel BA
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):489-93. PubMed ID: 12738325
[TBL] [Abstract][Full Text] [Related]
73. Is a low dose of concomitant chemotherapy with extended-field radiotherapy acceptable as an efficient treatment for cervical cancer patients with metastases to the para-aortic lymph nodes?
Kazumoto T; Kato S; Yokota H; Hasumi Y; Kino N; Horie K; Yoshida D; Mizukami T; Saito Y
Int J Gynecol Cancer; 2011 Nov; 21(8):1465-71. PubMed ID: 21892097
[TBL] [Abstract][Full Text] [Related]
74. Assessment of radiation doses to the para-aortic, pelvic, and inguinal lymph nodes delivered by image-guided adaptive brachytherapy in locally advanced cervical cancer.
Mohamed SM; Aagaard T; Fokdal LU; Pedersen EM; Lindegaard JC; Tanderup K
Brachytherapy; 2015; 14(1):56-61. PubMed ID: 25176182
[TBL] [Abstract][Full Text] [Related]
75. Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer.
Brockbank E; Kokka F; Bryant A; Pomel C; Reynolds K
Cochrane Database Syst Rev; 2011 Apr; (4):CD008217. PubMed ID: 21491407
[TBL] [Abstract][Full Text] [Related]
76. Early stage cervical cancer with negative pelvic lymph nodes: pattern of failure and complication following radical hysterectomy and adjuvant radiotherapy.
Chen SW; Liang JA; Yang SN; Lin FJ
Eur J Gynaecol Oncol; 2004; 25(1):81-6. PubMed ID: 15053068
[TBL] [Abstract][Full Text] [Related]
77. Radical radiotherapy versus brachytherapy plus surgery in carcinoma of the cervix 2A and 2B--long-term results from a randomized study 1968-1980.
Sundfør K; Trope CG; Kjørstad KE
Acta Oncol; 1996; 35 Suppl 8():99-107. PubMed ID: 9073055
[TBL] [Abstract][Full Text] [Related]
78. Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC). A phase I/II and pharmacokinetic study.
Micheletti E; La Face B; Bianchi E; Cagna E; Apostoli P; Ruggeri G; Verardi R; Sartori E
Am J Clin Oncol; 1997 Dec; 20(6):613-20. PubMed ID: 9391552
[TBL] [Abstract][Full Text] [Related]
79. Concurrent chemotherapy and adjuvant extended field irradiation after radical surgery for cervical cancer patients with lymph node metastases.
Cheng X; Cai SM; Li ZT; Wu XH; Ding YQ; Wang XE; Zang RY
Int J Gynecol Cancer; 2008; 18(4):779-84. PubMed ID: 17944922
[TBL] [Abstract][Full Text] [Related]
80. Impact of nodal boost irradiation and MR-based brachytherapy on oncologic outcomes in node-positive cervical cancer.
Tiwari R; Narayanan GS; Reddy VP; Vishwanathan B; Narayanan S; Venugopal R
Gynecol Oncol; 2021 Oct; 163(1):110-116. PubMed ID: 34304907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
